Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 106 citing Hansen: Efficacy and safety of second-generation antidepressants in the treatment of major.... (0.13 sec) 

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food …


I Kirsch, BJ Deacon, TB Huedo-Medina, A … - PLoS Med, 2008 - medicine.plosjournals.org
We obtained data on all clinical trials submitted to the US Food and Drug
Administration (FDA) for the licensing of the four new-generation
antidepressants for which full datasets were available. We then used meta- ...
Cited by 299 - Related articles - Cached - All 45 versions

Bulimia nervosa treatment: a systematic review of randomized controlled trials


JR Shapiro, ND Berkman, KA Brownley, JA … - International Journal of Eating Disorders, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 54 - Related articles - BL Direct - All 5 versions

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple- …

- psicofarmacologia.info [PDF] 
A Cipriani, TA Furukawa, G Salanti, JR … - The Lancet, 2009 - Elsevier
We systematically reviewed 117 randomised controlled trials (25 928
participants) from 1991 up to Nov 30, 2007, which compared any of the following
antidepressants at therapeutic dose range for the acute treatment of ...
Cited by 63 - Related articles - All 27 versions

Anorexia nervosa treatment: a systematic review of randomized controlled trials


CM Bulik, ND Berkman, KA Brownley, JA … - International Journal of Eating Disorders, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 40 - Related articles - BL Direct - All 5 versions

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major …

- adisonline.com [PDF] 
A Khan, A Bose, GS Alexopoulos, C Gommoll, … - Clinical drug investigation, 2007 - ingentaconnect.com
1173-2563/07/0007-0481/$44.95/0 © 2007 Adis Data Information BV. All rights
reserved. ... Arif Khan, 1 Anjana Bose, 2 George S. Alexopoulos, 3 Carl
Gommoll, 2 Dayong Li 2 and ... 1 Northwest Clinical Research Center, ...
Cited by 34 - Related articles - BL Direct - All 10 versions

Bupropion: pharmacology and therapeutic applications


KF Foley, KP DeSanty, RE Kast - Expert Review of Neurotherapeutics, 2006 - ingentaconnect.com
10.1586/14737175.6.9.1249 © 2006 Future Drugs Ltd ISSN 1473-7175 1249 ...
Kevin F Foley†, Kevin P DeSanty and Richard E Kast ... †Author for
correspondence University of Vermont, Department of Medical Laboratory and ...
Cited by 29 - Related articles - BL Direct - All 4 versions

Comparative benefits and harms of second-generation antidepressants: background paper …


G Gartlehner, BN Gaynes, RA Hansen, P … - Annals of Internal Medicine, 2008 - Am Coll Physicians
Data Sources: MEDLINE, EMBASE, PsychLit, Cochrane Central Register of Controlled
Trials, and International Pharmaceutical Abstracts from 1980 to April 2007,
limited to English-language articles. Reference lists of pertinent review ...
Cited by 29 - Related articles - All 6 versions

Antidepressant medications and other treatments of depressive disorders: a CINP Task …


N Sartorius, TC Baghai, DS Baldwin, B … - The International Journal of …, 2007 - Cambridge Univ Press
Page 1. Antidepressant medications and other treatments of depressive disorders:
a CINP Task Force report based on a review of evidence ...
Cited by 22 - Related articles - All 4 versions

Augmentation strategies for treatment-resistant depression: a literature review


AF Carvalho, JL Cavalcante, MS Castelo, MC … - Journal of Clinical Pharmacy and Therapeutics, 2007 - interscience.wiley.com
Background: The large majority of depressed patients fail to remit on the first
antidepressant prescribed. These patients with residual symptoms have higher
relapse rates and poorer outcomes than those who remit. Treatment-resistant ...
Cited by 19 - Related articles - BL Direct - All 4 versions

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with …


TA Pigott, A Prakash, LM Arnold, ST … - Current Medical Research and Opinion®, 2007 - informahealthcare.com
Background: Duloxetine and escitalopram were compared in an 8‑month,
randomized, double‑ blind, placebo‑controlled trial in adult outpatients
meeting DSM‑IV criteria for major depressive disorder (MDD). The results ...
Cited by 16 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google